Literature DB >> 22379085

Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Vignesh Gunasekharan1, Guylaine Haché, Laimonis Laimins.   

Abstract

The liver-enriched transcriptional activator protein (LAP) isoform of CCAAT/enhancer binding protein β (C/EBPβ) is shown to be a major activator of differentiation-dependent human papillomavirus (HPV) late gene expression, while the liver-enriched inhibitory protein (LIP) isoform negatively regulates late expression. In undifferentiated cells, LIPs act as dominant-negative repressors of late expression, and upon differentiation, LIP levels are significantly reduced, allowing LAP-mediated activation of the late promoter. Importantly, knockdown of C/EBPβ isoforms blocks activation of late gene expression from complete viral genomes upon differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379085      PMCID: PMC3347327          DOI: 10.1128/JVI.07239-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.

Authors:  P Descombes; U Schibler
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

Review 3.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

4.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

Authors:  T Chong; W K Chan; H U Bernard
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

5.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 6.  Human papillomavirus immortalization and transformation functions.

Authors:  Karl Münger; Peter M Howley
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

7.  NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region.

Authors:  S Kyo; M Inoue; Y Nishio; K Nakanishi; S Akira; H Inoue; M Yutsudo; O Tanizawa; A Hakura
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.

Authors:  K Butz; F Hoppe-Seyler
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.

Authors:  M G Frattini; H B Lim; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.

Authors:  T P Cripe; A Alderborn; R D Anderson; S Parkkinen; P Bergman; T H Haugen; U Pettersson; L P Turek
Journal:  New Biol       Date:  1990-05
View more
  16 in total

1.  Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Authors:  William K Songock; Matthew L Scott; Jason M Bodily
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

Review 2.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

Review 3.  Regulation of the life cycle of HPVs by differentiation and the DNA damage response.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Future Microbiol       Date:  2013-12       Impact factor: 3.165

4.  Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle.

Authors:  Jason M Bodily; Christine Hennigan; Gary A Wrobel; Cynthia M Rodriguez
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

5.  Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification.

Authors:  Vignesh Gunasekharan; Laimonis A Laimins
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity.

Authors:  Hana Vakili; Yan Jin; Savas Menticoglou; Peter A Cattini
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

Review 7.  Host cell restriction factors that limit transcription and replication of human papillomavirus.

Authors:  Samuel S Porter; Wesley H Stepp; James D Stamos; Alison A McBride
Journal:  Virus Res       Date:  2016-11-15       Impact factor: 3.303

8.  CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression.

Authors:  Christian Paris; Ieisha Pentland; Ian Groves; David C Roberts; Simon J Powis; Nicholas Coleman; Sally Roberts; Joanna L Parish
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 9.  Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.

Authors:  Cary Moody
Journal:  Viruses       Date:  2017-09-19       Impact factor: 5.048

10.  Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle.

Authors:  Vignesh Kumar Gunasekharan; Yan Li; Jorge Andrade; Laimonis A Laimins
Journal:  PLoS Pathog       Date:  2016-07-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.